REVIV(E)ing the ischaemic paradigm in heart failure: STICHes are needed

REVIV(E)ing the ischaemic paradigm in heart failure: STICHes are needed

Graphical Abstract Graphical Abstract Critical comparison between REVIVED-BCIS2 and STICH(ES) trials. NYHA, New York Heart Association; MI, myocardial infarction; LVEF, left ventricular ejection fraction; CAD, coronary artery disease; ACEi, angiotensin converting enzyme inhibitor; ARBs, angiotensin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European heart journal 2023-10, Vol.44 (37), p.3652-3654
Hauptverfasser: Rohde, Luis E, McMurray, John J V
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3654
container_issue 37
container_start_page 3652
container_title European heart journal
container_volume 44
creator Rohde, Luis E
McMurray, John J V
description Graphical Abstract Graphical Abstract Critical comparison between REVIVED-BCIS2 and STICH(ES) trials. NYHA, New York Heart Association; MI, myocardial infarction; LVEF, left ventricular ejection fraction; CAD, coronary artery disease; ACEi, angiotensin converting enzyme inhibitor; ARBs, angiotensin receptor blockers; ICD, implantable cardio-defibrillator; HF, heart failure; GDMT, guideline directed medical therapy. *Only baseline ICD was reported. †Based on the 2011 publication. ‡Based on the extended follow-up 2016 publication.
doi_str_mv 10.1093/eurheartj/ehad488
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2844678707</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/eurheartj/ehad488</oup_id><sourcerecordid>2844678707</sourcerecordid><originalsourceid>FETCH-LOGICAL-c338t-ad1587c7f2f6e850cc9696a1c5b05369cf3c8ac853ea182c7b1ae03282e6796a3</originalsourceid><addsrcrecordid>eNqNkDtPwzAUhS0EoqXwA1iQR5AIteP4xYaq0laqhASlYotc56ZJlRd2MvDvCbR0ZrrLd865-hC6puSBEs3G0LkMjGt3Y8hMEil1goaUh2GgRcRP0ZBQzQMh1McAXXi_I4QoQcU5GjDJQ661GKLZ63S9WN9O7_Jqi9sMcO5tZqDMLW6MM0m-LXFe4d8ZnJq86Bw84rfVYjIHj40DXAEkkFyis9QUHq4Od4Ten6eryTxYvswWk6dlYBlTbWASypW0Mg1TAYoTa7XQwlDLN4QzoW3KrDJWcQaGqtDKDTVAWKhCELIH2Qjd7nsbV3924Nu47D-GojAV1J2PQxVFQipJZI_SPWpd7b2DNG5cXhr3FVMS__iLj_7ig78-c3Oo7zYlJMfEn7AeuN8Dddf8o-8bnvd9cQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2844678707</pqid></control><display><type>article</type><title>REVIV(E)ing the ischaemic paradigm in heart failure: STICHes are needed</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Rohde, Luis E ; McMurray, John J V</creator><creatorcontrib>Rohde, Luis E ; McMurray, John J V</creatorcontrib><description>Graphical Abstract Graphical Abstract Critical comparison between REVIVED-BCIS2 and STICH(ES) trials. NYHA, New York Heart Association; MI, myocardial infarction; LVEF, left ventricular ejection fraction; CAD, coronary artery disease; ACEi, angiotensin converting enzyme inhibitor; ARBs, angiotensin receptor blockers; ICD, implantable cardio-defibrillator; HF, heart failure; GDMT, guideline directed medical therapy. *Only baseline ICD was reported. †Based on the 2011 publication. ‡Based on the extended follow-up 2016 publication.</description><identifier>ISSN: 0195-668X</identifier><identifier>EISSN: 1522-9645</identifier><identifier>DOI: 10.1093/eurheartj/ehad488</identifier><identifier>PMID: 37525996</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><ispartof>European heart journal, 2023-10, Vol.44 (37), p.3652-3654</ispartof><rights>The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2023</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c338t-ad1587c7f2f6e850cc9696a1c5b05369cf3c8ac853ea182c7b1ae03282e6796a3</citedby><cites>FETCH-LOGICAL-c338t-ad1587c7f2f6e850cc9696a1c5b05369cf3c8ac853ea182c7b1ae03282e6796a3</cites><orcidid>0000-0002-6557-393X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1584,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37525996$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rohde, Luis E</creatorcontrib><creatorcontrib>McMurray, John J V</creatorcontrib><title>REVIV(E)ing the ischaemic paradigm in heart failure: STICHes are needed</title><title>European heart journal</title><addtitle>Eur Heart J</addtitle><description>Graphical Abstract Graphical Abstract Critical comparison between REVIVED-BCIS2 and STICH(ES) trials. NYHA, New York Heart Association; MI, myocardial infarction; LVEF, left ventricular ejection fraction; CAD, coronary artery disease; ACEi, angiotensin converting enzyme inhibitor; ARBs, angiotensin receptor blockers; ICD, implantable cardio-defibrillator; HF, heart failure; GDMT, guideline directed medical therapy. *Only baseline ICD was reported. †Based on the 2011 publication. ‡Based on the extended follow-up 2016 publication.</description><issn>0195-668X</issn><issn>1522-9645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqNkDtPwzAUhS0EoqXwA1iQR5AIteP4xYaq0laqhASlYotc56ZJlRd2MvDvCbR0ZrrLd865-hC6puSBEs3G0LkMjGt3Y8hMEil1goaUh2GgRcRP0ZBQzQMh1McAXXi_I4QoQcU5GjDJQ661GKLZ63S9WN9O7_Jqi9sMcO5tZqDMLW6MM0m-LXFe4d8ZnJq86Bw84rfVYjIHj40DXAEkkFyis9QUHq4Od4Ten6eryTxYvswWk6dlYBlTbWASypW0Mg1TAYoTa7XQwlDLN4QzoW3KrDJWcQaGqtDKDTVAWKhCELIH2Qjd7nsbV3924Nu47D-GojAV1J2PQxVFQipJZI_SPWpd7b2DNG5cXhr3FVMS__iLj_7ig78-c3Oo7zYlJMfEn7AeuN8Dddf8o-8bnvd9cQ</recordid><startdate>20231001</startdate><enddate>20231001</enddate><creator>Rohde, Luis E</creator><creator>McMurray, John J V</creator><general>Oxford University Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6557-393X</orcidid></search><sort><creationdate>20231001</creationdate><title>REVIV(E)ing the ischaemic paradigm in heart failure: STICHes are needed</title><author>Rohde, Luis E ; McMurray, John J V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c338t-ad1587c7f2f6e850cc9696a1c5b05369cf3c8ac853ea182c7b1ae03282e6796a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rohde, Luis E</creatorcontrib><creatorcontrib>McMurray, John J V</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rohde, Luis E</au><au>McMurray, John J V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>REVIV(E)ing the ischaemic paradigm in heart failure: STICHes are needed</atitle><jtitle>European heart journal</jtitle><addtitle>Eur Heart J</addtitle><date>2023-10-01</date><risdate>2023</risdate><volume>44</volume><issue>37</issue><spage>3652</spage><epage>3654</epage><pages>3652-3654</pages><issn>0195-668X</issn><eissn>1522-9645</eissn><abstract>Graphical Abstract Graphical Abstract Critical comparison between REVIVED-BCIS2 and STICH(ES) trials. NYHA, New York Heart Association; MI, myocardial infarction; LVEF, left ventricular ejection fraction; CAD, coronary artery disease; ACEi, angiotensin converting enzyme inhibitor; ARBs, angiotensin receptor blockers; ICD, implantable cardio-defibrillator; HF, heart failure; GDMT, guideline directed medical therapy. *Only baseline ICD was reported. †Based on the 2011 publication. ‡Based on the extended follow-up 2016 publication.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>37525996</pmid><doi>10.1093/eurheartj/ehad488</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-6557-393X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0195-668X
ispartof European heart journal, 2023-10, Vol.44 (37), p.3652-3654
issn 0195-668X
1522-9645
language eng
recordid cdi_proquest_miscellaneous_2844678707
source Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title REVIV(E)ing the ischaemic paradigm in heart failure: STICHes are needed
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T14%3A38%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=REVIV(E)ing%20the%20ischaemic%20paradigm%20in%20heart%20failure:%20STICHes%20are%20needed&rft.jtitle=European%20heart%20journal&rft.au=Rohde,%20Luis%20E&rft.date=2023-10-01&rft.volume=44&rft.issue=37&rft.spage=3652&rft.epage=3654&rft.pages=3652-3654&rft.issn=0195-668X&rft.eissn=1522-9645&rft_id=info:doi/10.1093/eurheartj/ehad488&rft_dat=%3Cproquest_cross%3E2844678707%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2844678707&rft_id=info:pmid/37525996&rft_oup_id=10.1093/eurheartj/ehad488&rfr_iscdi=true